相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice
Ushasi Bhaumik et al.
MICROBES AND INFECTION (2023)
Engineering probiotic-derived outer membrane vesicles as functional vaccine carriers to enhance immunity against SARS-CoV-2
Jing Wo et al.
ISCIENCE (2023)
Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
Elisabet Bjanes et al.
ADVANCED NANOBIOMED RESEARCH (2023)
Characterization and Vaccine Potential of Outer Membrane Vesicles from Photobacterium damselae subsp. piscicida
Alexandra Teixeira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii
Sophie L. Higham et al.
JOURNAL OF INFECTION (2023)
Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases
Parisa Moradi Pordanjani et al.
PROCESS BIOCHEMISTRY (2023)
Heterologous Display of Chlamydia trachomatis PmpD Passenger at the Surface of Salmonella OMVs
Dung T. T. Huynh et al.
MEMBRANES (2023)
Production and purification of bacterial membrane vesicles for biotechnology applications: Challenges and opportunities
Keshia F. Castillo-Romero et al.
ELECTROPHORESIS (2023)
Effective Platform for the Production of Recombinant Outer Membrane Vesicles in Gram-Negative Bacteria
Anthicha Kunjantarachot et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2022)
Outer membrane vesicles (OMVs) enabled bio-applications: A critical review
Yikun Huang et al.
BIOTECHNOLOGY AND BIOENGINEERING (2022)
Cytolysin A (ClyA): A Bacterial Virulence Factor with Potential Applications in Nanopore Technology, Vaccine Development, and Tumor Therapy
Kazunori Murase
TOXINS (2022)
Packaging of Diisopropyl Fluorophosphatase (DFPase) in Bacterial Outer Membrane Vesicles Protects Its Activity at Extreme Temperature
Meghna Thakur et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial
Christine S. Rollier et al.
MSPHERE (2022)
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
Darielys Santana-Mederos et al.
RSC CHEMICAL BIOLOGY (2022)
Rapid Surface Display of mRNA Antigens by Bacteria-Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine
Yao Li et al.
ADVANCED MATERIALS (2022)
Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines
Lindley A. Barbee et al.
CLINICAL INFECTIOUS DISEASES (2022)
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine
Viola Viviani et al.
EXPERT REVIEW OF VACCINES (2022)
Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model
Kathryn A. Matthias et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague
Xiuran Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants
Linglei Jiang et al.
JOURNAL OF EXTRACELLULAR VESICLES (2022)
Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory
Amanda Izeli Portilho et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Outer membrane vesicles: A bacterial-derived vaccination system
Linda A. Lieberman
FRONTIERS IN MICROBIOLOGY (2022)
Insight into Prevention of Neisseria Gonorrhoeae: A Short Review
Vincenza La Fauci et al.
VACCINES (2022)
Engineering of a bacterial outer membrane vesicle to a nano-scale reactor for the biodegradation of β-lactam antibiotics
Ji-Min Woo et al.
JOURNAL OF BIOTECHNOLOGY (2022)
Bacteria-derived outer membrane vesicles engineered with over-expressed pre-miRNA as delivery nanocarriers for cancer therapy
Chenyang Cui et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2022)
Outer Membrane Vesicles: An Emerging Vaccine Platform
Dharmendra Kashyap et al.
VACCINES (2022)
The effects of different thermal and chemical stresses on release of outer membrane vesicles (OMVs) by ClearColi™
Zohreh Sadat Hosseini Zadeh et al.
ARCHIVES OF MICROBIOLOGY (2022)
Inactivation of the Mla system and outer-membrane phospholipase A results in disrupted outer-membrane lipid asymmetry and hypervesiculation in Bordetella pertussis
Eline F. de Jonge et al.
CURRENT RESEARCH IN MICROBIAL SCIENCES (2022)
Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis
Victor Araujo Correa et al.
DISEASES (2022)
Personalized cancer vaccines from bacteria-derived outer membrane vesicles with antibody-mediated persistent uptake by dendritic cells
Jie Liang et al.
FUNDAMENTAL RESEARCH (2022)
Conditional growth defect of Bordetella pertussis and Bordetella bronchiseptica ferric uptake regulator (fur) mutants
Eline F. de Jonge et al.
FEMS MICROBIOLOGY LETTERS (2022)
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine
R. Menezes Martins et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2021)
Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses
J. Timothy Prior et al.
PHARMACEUTICS (2021)
The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs)
Elham Sharif et al.
CURRENT MICROBIOLOGY (2021)
Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model
Elnaz Abbasifarid et al.
PLOS ONE (2021)
Outer Membrane Vesicle Induction and Isolation for Vaccine Development
Melanie D. Balhuizen et al.
FRONTIERS IN MICROBIOLOGY (2021)
Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B
Annett Kleinschmidt et al.
NPJ VACCINES (2021)
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses - results from two phase 2b randomized trials in adolescents
Timo Vesikari et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
Peter A. van der Ley et al.
FRONTIERS IN IMMUNOLOGY (2021)
Carbohydrate based meningococcal vaccines: past and present overview
Francesco Berti et al.
GLYCOCONJUGATE JOURNAL (2021)
Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults
Jiří Beran et al.
mSphere (2021)
Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
Vitor Rodrigues da Costa et al.
CELLS (2021)
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
Yara Ruiz Garcia et al.
NPJ VACCINES (2021)
Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis
M. J. Klouwens et al.
VACCINE (2021)
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
Keman Cheng et al.
NATURE COMMUNICATIONS (2021)
Experimental studies using OMV in a new platform do SARS-CoV-2 vaccines
Emanuelle B. Gaspar et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral Salmonella Infection
Jaikin E. Harrell et al.
PATHOGENS (2021)
OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response
Jurate Skerniskyte et al.
PATHOGENS (2021)
Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance
Zhuang Zhu et al.
MBIO (2021)
Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack
Ruchika Dehinwal et al.
MBIO (2021)
Differential Packaging Into Outer Membrane Vesicles Upon Oxidative Stress Reveals a General Mechanism for Cargo Selectivity
Nichole Orench-Rivera et al.
FRONTIERS IN MICROBIOLOGY (2021)
Outer membrane vesicle increases the efficacy of an influenza vaccine in a diet-induced obese mouse model
Tae-Young Lee et al.
IMMUNOLOGY LETTERS (2020)
Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants
Mohammadali Malekan et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2020)
A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection
Marina R. Pulido et al.
VACCINE (2020)
Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer
Kudelaidi Kuerban et al.
ACTA PHARMACEUTICA SINICA B (2020)
Combining Protein Ligation Systems to Expand the Functionality of Semi-Synthetic Outer Membrane Vesicle Nanoparticles
H. Bart van den Berg van Saparoea et al.
FRONTIERS IN MICROBIOLOGY (2020)
Outer Membrane Vesicles ofHelicobacter pylori7.13 as Adjuvants Promote Protective Efficacy AgainstHelicobacter pyloriInfection
Zifan Song et al.
FRONTIERS IN MICROBIOLOGY (2020)
Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice
Maryam Golshani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Engineered Bacterial Outer Membrane Vesicles as Multifunctional Delivery Platforms
Ruizhen Li et al.
FRONTIERS IN MATERIALS (2020)
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Min Li et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Biofilm formation and extracellular microvesicles-The way of foodborne pathogens toward resistance
Marija Begic et al.
ELECTROPHORESIS (2020)
Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity
E. Bartolini et al.
NATURE COMMUNICATIONS (2020)
Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract
Caitlin Ni Chasaide et al.
VACCINES (2020)
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
Isabelle Leduc et al.
PLOS PATHOGENS (2020)
Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
Patrick S. Gellings et al.
PATHOGENS (2020)
Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine
Terry Nolan et al.
VACCINE (2019)
Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials
Joseline Guetsop Zafack et al.
BMJ OPEN (2019)
A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
Maria Eugenia Zurita et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants
Susana Martinon et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Neisseria meningitidis and meningococcal disease: recent discoveries and innovations
Robert C. Read
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial
Marco Aurelio P. Safadi et al.
VACCINE (2019)
The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
Evgeny A. Semchenko et al.
CLINICAL INFECTIOUS DISEASES (2019)
Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response
Wei Cai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Outer Membrane Vesicle-Host Cell Interactions
Jessica D. Cecil et al.
MICROBIOLOGY SPECTRUM (2019)
Environmental Decontamination of a Chemical Warfare Simulant Utilizing a Membrane Vesicle-Encapsulated Phosphotriesterase
Nathan J. Alves et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes
Qiong Liu et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA
Helia Namazi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Federico Martinon-Torres et al.
JOURNAL OF INFECTION (2018)
Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines A Phase 2 Randomized Study
Leszek Szenborn et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
Nan-Chang Chiu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
Xavier Saez-Llorens et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Immunization With Skp Delivered on Outer Membrane Vesicles Protects Mice Against Enterotoxigenic Escherichia coli Challenge
Michael P. Hays et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation
H. Bart van den Berg van Saparoea et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function
Federico Martinon-Torres et al.
PEDIATRICS (2018)
Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study
Jo Anne Welsch et al.
VACCINE (2018)
Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial
Mercedes Macias Parra et al.
VACCINE (2018)
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci
Serena Giuntini et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Endogenous and Exogenous Natural Adjuvants for Vaccine Development
Azam Bolhassani et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles
Hannah C. Watkins et al.
VACCINE (2017)
Membrane Distribution of the Pseudomonas Quinolone Signal Modulates Outer Membrane Vesicle Production in Pseudomonas aeruginosa
Catalina Florez et al.
MBIO (2017)
Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
Arif Tasleem Jan
FRONTIERS IN MICROBIOLOGY (2017)
Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA
Martina Maritan et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2017)
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
Manish Sadarangani et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery
Yehou M. D. Gnopo et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Bioengineering bacterial outer membrane vesicles as vaccine platform
Matthias J. H. Gerritzen et al.
BIOTECHNOLOGY ADVANCES (2017)
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles
Merijn L. M. Salverda et al.
VACCINE (2016)
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea-A randomised trial
Hoan Jong Lee et al.
VACCINE (2016)
Bacterial Nanobioreactors-Directing Enzyme Packaging into Bacterial Outer Membrane Vesicles
Nathan J. Alves et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Outer membrane vesicles as platform vaccine technology
Leo van der Pol et al.
BIOTECHNOLOGY JOURNAL (2015)
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months
Fiona McQuaid et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria
Jana Klimentova et al.
MICROBIOLOGICAL RESEARCH (2015)
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
Carmen Schwechheimer et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Persistence of Meningococcal Antibodies and Response to a Third Dose After a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
Xavier Saez-Llorens et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
Kirsten P. Perrett et al.
VACCINE (2015)
Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization
Kirsten Kuipers et al.
VACCINE (2015)
Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children
Timo Vesikari et al.
VACCINE (2015)
Outer membrane vesicles as platform vaccine technology
Leo van der Pol et al.
BIOTECHNOLOGY JOURNAL (2015)
Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
Vipul Gujrati et al.
ACS NANO (2014)
Decoration of Outer Membrane Vesicles with Multiple Antigens by Using an Autotransporter Approach
Maria H. Daleke-Schermerhorn et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Microbial biosynthesis of designer outer membrane vesicles
Jenny L. Baker et al.
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C. Read et al.
LANCET (2014)
Bioengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?
Vipul B. Gujrati et al.
NANOMEDICINE (2014)
Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria
Heramb M. Kulkarni et al.
MICROBIOLOGY-SGM (2014)
Persistence of Bactericidal Antibodies to 5 Years of Age After Immunization With Serogroup B Meningococcal Vaccines at 6, 8, 12 and 40 Months of Age
Fiona McQuaid et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Positional Assembly of Enzymes on Bacterial Outer Membrane Vesicles for Cascade Reactions
Miso Park et al.
PLOS ONE (2014)
Genetic Diversity and Levels of Expression of Factor H Binding Protein among Carriage Isolates of Neisseria meningitidis
Ludovic Lemee et al.
PLOS ONE (2014)
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II) Effects of variations of the OMV and protein content on immunogenicity and reactogenicity
Susanna Esposito et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
Matthew D. Snape et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Production of Outer Membrane Vesicles and Outer Membrane Tubes by Francisella novicida
William D. McCaig et al.
JOURNAL OF BACTERIOLOGY (2013)
Stress-Induced Outer Membrane Vesicle Production by Pseudomonas aeruginosa
Ian A. MacDonald et al.
JOURNAL OF BACTERIOLOGY (2013)
Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines
Bas van de Waterbeemd et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
Timo Vesikari et al.
LANCET (2013)
Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses A Follow-on Study to a Randomized Clinical Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606T
Roman I. Koning et al.
RESEARCH IN MICROBIOLOGY (2013)
Application of Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1
Mohammad Reza Aghasadeghi et al.
CURRENT HIV RESEARCH (2012)
Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial
Nicoletta Gossger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Biogenesis of Outer Membrane Vesicles in Serratia marcescens Is Thermoregulated and Can Be Induced by Activation of the Rcs Phosphorelay System
Kenneth J. McMahon et al.
JOURNAL OF BACTERIOLOGY (2012)
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
Maria Elena Santolaya et al.
LANCET (2012)
A structurally informed autotransporter platform for efficient heterologous protein secretion and display
Wouter S. P. Jong et al.
MICROBIAL CELL FACTORIES (2012)
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
Xilian Bai et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate
Cristian J. A. Asensio et al.
VACCINE (2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
P. B. Keiser et al.
VACCINE (2011)
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
Adam Kulp et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Variation of Physiochemical Properties and Cell Association Activity of Membrane Vesicles with Growth Phase in Pseudomonas aeruginosa
Yosuke Tashiro et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2010)
Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
Jamie Findlow et al.
CLINICAL INFECTIOUS DISEASES (2010)
Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life A Randomized Comparative Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
David J. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process
Bas van de Waterbeemd et al.
VACCINE (2010)
Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media
Nikos Tsolakos et al.
VACCINE (2010)
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
Wendell D. Zollinger et al.
VACCINE (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
PROTEOMICS IN GRAM-NEGATIVE BACTERIAL OUTER MEMBRANE VESICLES
Eun-Young Lee et al.
MASS SPECTROMETRY REVIEWS (2008)
Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli
Eun-Young Lee et al.
PROTEOMICS (2007)
Release of outer membrane vesicles by gram-negative bacteria is a novel envelope stress response
Amanda J. McBroom et al.
MOLECULAR MICROBIOLOGY (2007)
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles
A Gorringe et al.
VACCINE (2005)
Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex
T Popovic et al.
EMERGING INFECTIOUS DISEASES (2000)